Although CSF N-Ag concentrations were not significantly different between patient groups, patients with COVID-19 had higher concentrations of CSF NfL compared with controls, and neurosymptomatic patients had a more marked immune activation biomarker profile, suggesting that the magnitude of the CNS immune response, possibly triggered by viral components, contributes to the neuropathogenesis of COVID-19. Here, NEFL is linked to COVID-19.